BlackRock Unconstrained Equity Fund OCSE:NOVO B Holdings History
BlackRock Unconstrained Equity Fund's Novo Nordisk AS Holding Summary
As of 2025-04-30, BlackRock Unconstrained Equity Fund held - shares of Novo Nordisk AS(OCSE:NOVO B), totaling N/A. This investment constitutes 0% of their stock portfolio, and BlackRock Unconstrained Equity Fund now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2022Q2. And since then BlackRock Unconstrained Equity Fund has made 8 purchases of OCSE:NOVO B, at an average price of kr708.59, for a total of 1.07 Mil shares. In addition, there have been 4 sales at an average price of kr520.93 for 1.07 Mil shares. Based on historical transaction data and OCSE:NOVO B's current price of kr414.60, BlackRock Unconstrained Equity Fund's estimated gain on his OCSE:NOVO B holdings is kr-200.97 Mil, reflecting a -26.48% gain to date.
BlackRock Unconstrained Equity Fund OCSE:NOVO B (kr414.60) Holding Chart
BlackRock Unconstrained Equity Fund OCSE:NOVO B (kr414.60) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
